With the proper safeguards, creative destruction — the process by which the new replaces the old — remains the way to greater economic growth and prosperity
If we think it is necessary to (re)think about innovation with spiritual exercises, to what extent should Confucianist philosophy, for example, which is dominant in Asia, not be a way to follow?
To create something truly novel, we need people with different backgrounds, knowledge and talents, people from different industries, to come together. That's why, ideally, innovation shouldn't be geographically constrained, says Darden professor
Non-fungible tokens shot to popularity earlier this year with headline-grabbing, multi-million-dollar sales of digital-only artworks. Globally, sales and token values have since fallen, while in India, NFT usage is slowly catching up. How much of it is hype and how much is here to stay?
When it comes to innovations in the face of global pandemics, business as usual for our innovation system is unlikely to apply. There are strong pressures to make it freely available, and in the process, push down the return to any R&D that has been conducted
From an ahead-of-its-times outfit to bring technology to 'medico marketing' to a multinational tech company offering AI and NLP platforms to the world's biggest drugmakers, Indegene has come a long way. The Covid-19 pandemic, however, showed that the Bengaluru company was only getting started. In this special briefing, Manish Gupta, co-founder and CEO of Indegene, recalls the early days of Indegene, and talks about what lies ahead
After a year of buying boring staples in bulk, everything is about to change—and brands need to be ready to innovate
Medical delivery firm Zipline has been working in Ghana and Rwanda to transport Covid-19 and other vaccines. Its head of global regulatory affairs Dan Czerwonka speaks about the advantages and challenges of deploying unmanned aircraft systems in other countries
Through innovation and pivots, these startups are helping rural India, which has little or no access to healthcare including, hospitals, doctors, diagnostics, or medicines, cope with the pandemic
Amid concerns surrounding Sputnik V and the launch of a single-dose vaccine, Indian companies, including Hetero, Stelis, Biopharma and Gland Pharma are on track to make millions of doses of the Russian vaccine in a bid to alleviate the country's supply constraints